Glycoprotein G (gG) production profile during infectious laryngotracheitis virus (ILTV) infection

PLoS One. 2019 Aug 21;14(8):e0219475. doi: 10.1371/journal.pone.0219475. eCollection 2019.

Abstract

Glycoprotein G (gG) is a conserved protein, and it has been described as a chemokine-binding protein in most members of the alphaherpesviruses. In case of the infectious laryngotracheitis virus (ILTV), an alphaherpesvirus that infects chickens, this protein is a virulence factor that plays an immunomodulatory role in the chicken immune response. Nevertheless, the gG production profile during ILTV infection has not yet been studied. In this study, we developed monoclonal antibodies in order to determine the gG production profile during ILTV infection in chicken hepatocellular carcinoma (LMH) cell cultures as well as embryonated specific-pathogen-free (SPF) chicken eggs and SPF chickens using a sandwich enzyme-linked immunosorbent assay (ELISA). Despite the fact that inoculated LMH cell cultures showed an increase in both gG production and viral genome copy number up to 96 h after inoculation, we observed that gG production started earlier than the increase in viral genome copy number in ILTV infected embryonated SPF chicken eggs. Likewise, a gG production peak and an increase of viral genome copy number was observed prior to the appearance of clinical signs in infected SPF chickens. According to the production profiles, gG was also produced quite early in eggs and chickens inoculated with ILTV. These findings contribute to the knowledge of the gG role during the ILTV infection as a virulence factor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Baculoviridae / genetics
  • Chickens / virology
  • Genome, Viral / genetics
  • Herpesviridae Infections / metabolism*
  • Herpesvirus 1, Gallid / genetics
  • Herpesvirus 1, Gallid / physiology*
  • Recombinant Proteins / biosynthesis
  • Recombinant Proteins / genetics
  • Recombinant Proteins / immunology
  • Sf9 Cells
  • Spodoptera
  • Viral Envelope Proteins / biosynthesis*
  • Viral Envelope Proteins / genetics
  • Viral Envelope Proteins / immunology

Substances

  • Antibodies, Monoclonal
  • Recombinant Proteins
  • Viral Envelope Proteins

Grants and funding

This study was co-financially supported by Programa Nacional de Innovación Agraria (PNIA) of the Peruvian Government and Laboratorios de Investigación y Desarrollo - FARVET under the contract 021-2015-INIA-PNIA/UPMSI/IE. JB, SMR and MFD were granted by the Programa Nacional de Innovación Agraria (PNIA). These funders supported salaries for JB, SMR, RM, RCG and KPA and supplied materials for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.